Noxopharm (ASX: NOX) Share Price

NOX

$0.077▼-3.75%

$23.7MRank #1250 on ASXHealthcareBiotechnology

Prices updated 13 June 2026, 9:40 am AEST · Data: Financial Modeling Prep

Market Cap

$23.7M

Volume

10K

P/E Ratio

-3.69

EPS

-$0.0063

Dividend Yield

0.00%

52-Week High

$0.135

52-Week Low

$0.043

Beta

0.023

Noxopharm (ASX: NOX) is an Australian-listed company in the Healthcare sector with a market capitalisation of $23.7M and the 1250th-largest security on the ASX by market capitalisation. The NOX share price is $0.077, down 3.75% today and up 18.46% over the past 12 months. Shares have traded between $0.043 and $0.135 over the past 52 weeks. In its most recent reported period (ending 31 Dec 2025), Noxopharm reported revenue of $0 and a net loss of $1.8M.

Charts

$0.08

24H Range

$0.077

52-Week Range

$0.043

$0.135

About Noxopharm Limited

Noxopharm Limited is an Australian drug development company with an international reach, focused on pioneering new treatment options for a range of solid tumor cancers and septic shock. Its primary asset, Veyonda, functions as an adjuvant therapy designed to augment the effectiveness of chemotherapy and radiotherapy in treating late-stage cancers. Beyond Veyonda, the company's robust development pipeline encompasses several key programs: The DARRT program, currently in Phase 1b/2a clinical trials, is addressing metastatic castration-resistant prostate cancer and other solid tumors. The LuPIN program explores a combined therapy of Veyonda and 177Lu-PSMA-617 for advanced prostate cancer. The IONIC program combines Veyonda with Bristol Myers Squibb's checkpoint inhibitor, Opdivo, targeting various solid tumor types. Its Chemotherapy Enhancement Program (CEP) integrates Veyonda with carboplatin for patients suffering from refractory solid tumors in areas such as the breast, head and neck, lung, prostate, and ovaries. Furthermore, the NOXCOVID Program is conducting a dose escalation and expansion study of NOX66 for the treatment of COVID-19 infection. The company is also investigating potential treatments for pancreatic cancer and glioblastoma. Noxopharm collaborates with the Hudson Institute of Medical Research and The Australian National University on the research and development of therapeutic drugs for inflammatory disorders. Incorporated in 2015, the company's operations are based in Chatswood, Australia.

IPO Date

9 Aug 2016

CEO

Shawn Van Boheemen

Website

noxopharm.com

Key Financial Data

Revenue (Quarterly)	$0
Net Income (Quarterly)	$-1.8M
Total Assets	$4.7M
Total Debt	$4.2M
Free Cash Flow	$-4.6M
Return on Equity	163.32%
Profit Margin	—
Operating Margin	—

NOX Frequently Asked Questions

What is the Noxopharm (ASX: NOX) share price?

The NOX share price is $0.077, down 3.75% for the day, based on the latest available ASX market data.

What is Noxopharm's market capitalisation?

Noxopharm has a market capitalisation of $23.7M, making it the 1250th-largest security listed on the ASX.

Does Noxopharm pay a dividend?

NOX does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.

Is Noxopharm profitable?

In its most recent reported period (ending 31 Dec 2025), NOX reported revenue of $0 and a net loss of $1.8M.

How many NOX shares are on issue?

Noxopharm has approximately 307,237,948 shares on issue, based on its market capitalisation of $23.7M and current share price.

What sector is Noxopharm in?

Noxopharm is classified in the Healthcare sector, within the Biotechnology industry on the ASX.

When did Noxopharm list on the ASX?

Noxopharm listed on the Australian Securities Exchange on 9 Aug 2016.

Latest News

Noxopharm (ASX:NOX) shares Skyrocket 40% Today- Here’s Why?

Kalkine26 May 2026

Noxopharm (ASX:NOX) shares Skyrocket 40% Today- Here’s Why? Kalkine

Noxopharm unveils new cancer immunotherapy potential - ICYMI

Proactive financial news9 June 2026

Noxopharm unveils new cancer immunotherapy potential - ICYMI Proactive financial news

We Think Noxopharm (ASX:NOX) Has A Fair Chunk Of Debt

simplywall.st4 Dec 2025

We Think Noxopharm (ASX:NOX) Has A Fair Chunk Of Debt simplywall.st

Insights: Noxopharm Ltd (ASX:NOX)

smallcaps.com.au30 Oct 2025

Insights: Noxopharm Ltd (ASX:NOX) smallcaps.com.au

Noxopharm CEO discusses Sofra cancer platform

Proactive financial news5 June 2026

Noxopharm CEO discusses Sofra cancer platform Proactive financial news

Similar Companies

Company	Market Cap	Price	P/E	Div Yield	1D Change
RHYRhythm Biosciences Limited	$38.9M	$0.11	-4.75	0.00%	–+0.00%
HMDHeraMED Limited	$30.1M	$0.038	-5.14	0.00%	▲+2.70%
BDXBCAL Diagnostics Limited	$25.8M	$0.07	-2.45	0.00%	▲+2.94%
NC6Nanollose Limited	$18.6M	$0.053	-2.45	0.00%	–+0.00%
AGNArgenica Therapeutics Limited	$16.7M	$0.13	-2.48	0.00%	▲+4.00%
PABPatrys Limited	$14.7M	$0.043	-0.62	0.00%	▲+2.38%
IDTIDT Australia Limited	$14.5M	$0.034	-4.15	0.00%	▲+3.03%
OSLOncoSil Medical Limited	$10.6M	$0.565	-1.00	0.00%	▲+7.62%

Largest Healthcare Stocks on the ASX

Company	Market Cap	Price	1Y Change
CSLCSL Limited	$51.49B	$107.51	▼-55.35%
RMDResMed Inc.	$40.21B	$27.72	▼-28.70%
SIGSigma Healthcare Limited	$30.48B	$2.64	▼-18.01%
FPHFisher & Paykel Healthcare Corporation Limited	$18.93B	$32.23	▼-5.74%
PMEPro Medicus Limited	$17.13B	$164.00	▼-41.41%
MPLMedibank Private Limited	$13.69B	$4.97	▲+1.22%
SHLSonic Healthcare Limited	$9.98B	$20.20	▼-24.66%
RHCRamsay Health Care Limited	$8.93B	$38.82	▲+5.16%
COHCochlear Limited	$6.79B	$103.75	▼-62.07%
TLXTelix Pharmaceuticals Limited	$4.61B	$13.60	▼-47.02%

Browse all ASX sectors

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
12 June 2026	$0.077	$0.077	$0.077	$0.077	10K	▼-3.75%
11 June 2026	$0.08	$0.081	$0.08	$0.08	35K	▼-5.88%
10 June 2026	$0.077	$0.086	$0.077	$0.085	309K	▲+6.25%
9 June 2026	$0.079	$0.08	$0.079	$0.08	60K	▼-1.23%
8 June 2026	$0.075	$0.081	$0.075	$0.081	411K	▲+1.25%
5 June 2026	$0.075	$0.08	$0.075	$0.08	377K	▲+2.56%
4 June 2026	$0.076	$0.078	$0.072	$0.078	207K	–+0.00%
3 June 2026	$0.076	$0.078	$0.072	$0.078	207K	▲+8.33%
2 June 2026	$0.085	$0.085	$0.072	$0.072	680K	▼-15.29%
1 June 2026	$0.083	$0.085	$0.083	$0.085	125K	▲+2.41%
29 May 2026	$0.086	$0.087	$0.083	$0.083	176K	▼-2.35%
28 May 2026	$0.089	$0.089	$0.085	$0.085	602K	▼-3.41%
27 May 2026	$0.087	$0.09	$0.085	$0.088	279K	▲+2.33%
26 May 2026	$0.082	$0.095	$0.077	$0.086	2.7M	▲+43.33%
25 May 2026	$0.06	$0.06	$0.06	$0.06	45K	▼-1.64%
22 May 2026	$0.061	$0.065	$0.06	$0.061	79K	▼-4.69%
21 May 2026	$0.065	$0.065	$0.06	$0.064	156K	–+0.00%
20 May 2026	$0.06	$0.064	$0.06	$0.064	57K	▲+4.92%
19 May 2026	$0.06	$0.061	$0.06	$0.061	56K	▲+1.67%
18 May 2026	$0.06	$0.06	$0.06	$0.06	5.1K	–+0.00%
15 May 2026	$0.064	$0.064	$0.06	$0.06	256K	▼-4.76%
14 May 2026	$0.064	$0.064	$0.063	$0.063	16K	–+0.00%
13 May 2026	$0.064	$0.064	$0.063	$0.063	16K	▼-5.97%
12 May 2026	$0.067	$0.067	$0.067	$0.067	25K	▼-1.47%
11 May 2026	$0.07	$0.07	$0.068	$0.068	65K	▼-2.86%
8 May 2026	$0.07	$0.07	$0.07	$0.07	4.6K	–+0.00%
7 May 2026	$0.071	$0.071	$0.07	$0.07	142K	▼-1.41%
6 May 2026	$0.071	$0.071	$0.071	$0.071	106K	▲+1.43%
5 May 2026	$0.07	$0.07	$0.07	$0.07	33K	▼-1.41%
4 May 2026	$0.08	$0.08	$0.071	$0.071	100K	▼-5.33%

About Noxopharm Limited

IPO Date

9 Aug 2016

CEO

Shawn Van Boheemen

Website

noxopharm.com

NOX Frequently Asked Questions

What is the Noxopharm (ASX: NOX) share price?

The NOX share price is $0.077, down 3.75% for the day, based on the latest available ASX market data.

What is Noxopharm's market capitalisation?

Noxopharm has a market capitalisation of $23.7M, making it the 1250th-largest security listed on the ASX.

Does Noxopharm pay a dividend?

NOX does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.

Is Noxopharm profitable?

In its most recent reported period (ending 31 Dec 2025), NOX reported revenue of $0 and a net loss of $1.8M.

How many NOX shares are on issue?

Noxopharm has approximately 307,237,948 shares on issue, based on its market capitalisation of $23.7M and current share price.

What sector is Noxopharm in?

Noxopharm is classified in the Healthcare sector, within the Biotechnology industry on the ASX.

When did Noxopharm list on the ASX?

Noxopharm listed on the Australian Securities Exchange on 9 Aug 2016.

Company

Market Cap

Price

P/E

Div Yield

1D Change

RHYRhythm Biosciences Limited

$38.9M

$0.11

-4.75

0.00%

–+0.00%

HMDHeraMED Limited

$30.1M

$0.038

-5.14

0.00%

▲+2.70%

BDXBCAL Diagnostics Limited

$25.8M

$0.07

-2.45

0.00%

▲+2.94%

NC6Nanollose Limited

$18.6M

$0.053

-2.45

0.00%

–+0.00%

AGNArgenica Therapeutics Limited

$16.7M

$0.13

-2.48

0.00%

▲+4.00%

PABPatrys Limited

$14.7M

$0.043

-0.62

0.00%

▲+2.38%

IDTIDT Australia Limited

$14.5M

$0.034

-4.15

0.00%

▲+3.03%

OSLOncoSil Medical Limited

$10.6M

$0.565

-1.00

0.00%

▲+7.62%

Company

Market Cap

Price

1Y Change

CSLCSL Limited

$51.49B

$107.51

▼-55.35%

RMDResMed Inc.

$40.21B

$27.72

▼-28.70%

SIGSigma Healthcare Limited

$30.48B

$2.64

▼-18.01%

FPHFisher & Paykel Healthcare Corporation Limited

$18.93B

$32.23

▼-5.74%

PMEPro Medicus Limited

$17.13B

$164.00

▼-41.41%

MPLMedibank Private Limited

$13.69B

$4.97

▲+1.22%

SHLSonic Healthcare Limited

$9.98B

$20.20

▼-24.66%

RHCRamsay Health Care Limited

$8.93B

$38.82

▲+5.16%

COHCochlear Limited

$6.79B

$103.75

▼-62.07%

TLXTelix Pharmaceuticals Limited

$4.61B

$13.60

▼-47.02%

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
12 June 2026	$0.077	$0.077	$0.077	$0.077	10K	▼-3.75%
11 June 2026	$0.08	$0.081	$0.08	$0.08	35K	▼-5.88%
10 June 2026	$0.077	$0.086	$0.077	$0.085	309K	▲+6.25%
9 June 2026	$0.079	$0.08	$0.079	$0.08	60K	▼-1.23%
8 June 2026	$0.075	$0.081	$0.075	$0.081	411K	▲+1.25%
5 June 2026	$0.075	$0.08	$0.075	$0.08	377K	▲+2.56%
4 June 2026	$0.076	$0.078	$0.072	$0.078	207K	–+0.00%
3 June 2026	$0.076	$0.078	$0.072	$0.078	207K	▲+8.33%
2 June 2026	$0.085	$0.085	$0.072	$0.072	680K	▼-15.29%
1 June 2026	$0.083	$0.085	$0.083	$0.085	125K	▲+2.41%
29 May 2026	$0.086	$0.087	$0.083	$0.083	176K	▼-2.35%
28 May 2026	$0.089	$0.089	$0.085	$0.085	602K	▼-3.41%
27 May 2026	$0.087	$0.09	$0.085	$0.088	279K	▲+2.33%
26 May 2026	$0.082	$0.095	$0.077	$0.086	2.7M	▲+43.33%
25 May 2026	$0.06	$0.06	$0.06	$0.06	45K	▼-1.64%
22 May 2026	$0.061	$0.065	$0.06	$0.061	79K	▼-4.69%
21 May 2026	$0.065	$0.065	$0.06	$0.064	156K	–+0.00%
20 May 2026	$0.06	$0.064	$0.06	$0.064	57K	▲+4.92%
19 May 2026	$0.06	$0.061	$0.06	$0.061	56K	▲+1.67%
18 May 2026	$0.06	$0.06	$0.06	$0.06	5.1K	–+0.00%
15 May 2026	$0.064	$0.064	$0.06	$0.06	256K	▼-4.76%
14 May 2026	$0.064	$0.064	$0.063	$0.063	16K	–+0.00%
13 May 2026	$0.064	$0.064	$0.063	$0.063	16K	▼-5.97%
12 May 2026	$0.067	$0.067	$0.067	$0.067	25K	▼-1.47%
11 May 2026	$0.07	$0.07	$0.068	$0.068	65K	▼-2.86%
8 May 2026	$0.07	$0.07	$0.07	$0.07	4.6K	–+0.00%
7 May 2026	$0.071	$0.071	$0.07	$0.07	142K	▼-1.41%
6 May 2026	$0.071	$0.071	$0.071	$0.071	106K	▲+1.43%
5 May 2026	$0.07	$0.07	$0.07	$0.07	33K	▼-1.41%
4 May 2026	$0.08	$0.08	$0.071	$0.071	100K	▼-5.33%